Answers are grounded in this paper and cite their sources.
Mucormycosis is a life-threatening fungal infection commonly noticed in individuals with uncontrolled diabetes mellitus, prolonged corticosteroid therapy to the underlying systemic diseases, prolonged hospital stays, malnutrition, Acquired Immunodeficiency Syndrome (AIDS), chronic alcoholism, liver disease, and renal failure. In India, an increased number of patients with mucormycosis have been reported since the coronavirus disease 2019 (COVID-19) pandemic. This case series aims to discuss the cases of mucormycosis of the oral cavity associated with a history of COVID-19 infection that were clinically, radiologically, histologically diagnosed, and treated during the post-COVID period. Early diagnosis, thorough understanding of disease progression, and immediate, aggressive treatment are critical for successful recovery and improved outcomes in mucormycosis patients with a history of COVID-19, considering the disease’s high mortality rate.
No takes yet. Share an insight, caveat, or question.
Kodati et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: